Bansal notes about 21% of US households now have a GLP-1 user, up from 9% in early 2025, and says India is watching the shift in fashion closely.
Recap by typeshit. Post by Dr. Rakesh Bansal on X.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
An explainer on the effectiveness of oral Wegovy, the daily semaglutide pill. Little detail is available beyond the headline.
A thin search result says Lilly has cut the price of its weight loss drug. No figures, dates or product names are included.
Loading…